Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 24
Phase 32

Trial Status

Completed6

Role Distribution

Principal Investigator2
Other Roles4
PI Rate33%

Activity Timeline

Research Network

Collaboration Network

13 collaborators·13 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven M. Horwitz, MD

Memorial Sloan Kettering Cancer Center

Related
4 trials

Shared therapeutic areas:

LymphomaLeukemia

Worked with same sponsors:

Hackensack Meridian HealthM.D. Anderson Cancer Center+5 more
Collaborated on 1 trial
Similarity Score24%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesAnemia+4 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score23%

Patricia L. Myskowski, MD

Memorial Sloan Kettering Cancer Center

Related
1 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

Hackensack Meridian HealthM.D. Anderson Cancer Center+5 more
Collaborated on 1 trial
Similarity Score14%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LeukemiaLymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

LymphomaMyelodysplastic Syndromes

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Anjali Advani, MD

The Cleveland Clinic

Related
7 trials

Shared therapeutic areas:

LeukemiaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Unspecified Adult Solid Tumor, Protocol SpecificFatigue

Worked with same sponsors:

Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)
Similarity Score7%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LymphomaLeukemia

Worked with same sponsors:

M.D. Anderson Cancer CenterMemorial Sloan Kettering Cancer Center+1 more
Similarity Score7%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic Syndromes

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score7%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

FatiguePrecancerous Conditions

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT00003341Phase 3StudyChair

Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy

AnemiaLeukemiaLymphoma+1 more
Completed
NCT00005040Phase 2StudyChair

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma

Lymphoma
Completed
NCT00005805Phase 3StudyChair

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

Chronic Myeloproliferative DisordersFatigueLeukemia+5 more
Completed
NCT00030849Phase 2StudyChair

Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma

Lymphoma
Completed
NCT00255801Phase 2PrincipalInvestigator

Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma

Lymphoma
Completed
NCT01132807Phase 2PrincipalInvestigator

Chemotherapy Based on Positron Emission Tomography Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Lymphoma
Completed

All 6 trials loaded